BioSpace News Archive

Policy

Repros Therapeutics Inc. Submits New Drug Application To FDA For Androxal®

February 2, 2015
·
3 min read
Drug Development

Aquinox Pharmaceuticals Completes Enrollment In The Phase 2 FLAGSHIP Trial Of AQX-1125 In Chronic Obstructive Pulmonary Disease Exacerbations

February 2, 2015
·
5 min read
FDA

IRIDEX Corporation Receives FDA Clearance for Cyclo G6™ Laser System for the Treatment of Multiple Stages of Glaucoma

February 2, 2015
·
3 min read
Drug Development

Pluristem Therapeutics Announces Significant New Finding From Its Phase I/II Muscle Injury Trial And Excellent Safety Profile For PLX-PAD Cells At Twelve Months

February 2, 2015
·
5 min read
Drug Development

Protalix Biotherapeutics, Inc. Completes Enrollment In Phase I/II Clinical Trial Of PRX-102 For Fabry Disease

February 2, 2015
·
5 min read
Business

IntelliPharmaCeutics Reports The Signing Of An Exclusive Licensing And Manufacturing Agreement With TEVA Pharmaceuticals USA For An Extended Release Oral Drug Product Candidate

February 2, 2015
·
6 min read
Drug Development

Lion Biotechnologies, Inc. Announces Allowance Of IND Application To Begin New Phase 2 Study In Metastatic Melanoma

February 2, 2015
·
2 min read
Business

Bio Blast Announces Key Leadership Changes

February 2, 2015
·
5 min read
BioCapital

Rexahn Pharmaceuticals, Inc. To Present At The 17th Annual Biotechnology Industry Organization (BIO) CEO & Investor Conference

February 2, 2015
·
2 min read
Biotech Bay

Raptor Pharmaceutical Inc. To Present At The 2015 Leerink Global Healthcare Conference

February 2, 2015
·
1 min read